NCT00652444View on ClinicalTrials.gov

Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Hypercholesterolemia
Interventions
DRUG

ezetimibe

ezetimibe 10mg. Blood samples were collected again at the end of study treatment, week 6.

DRUG

simvastatin

simvastatin 20mg . Blood samples were collected again at the end of study treatment, week 6.

DRUG

Placebo (Unspecified)

Matching ezetimibe placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00652444 - Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151) | Biotech Hunter | Biotech Hunter